vaccine development — grants

Sort

82,697 grants matching “vaccine development”

Cell-specific nanocarrier with endocytic and endosomolytic activities for therapeutic genome editing

$736,158

Kit S Lam · University Of California At Davis · UG3 · FY2019 · TR

CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS

$736,081

Igor I Slukvin · University Of Wisconsin-Madison · R24 · FY2019 · OD

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment Following Hematopoietic Stem Cell Transplantation

$735,811

Michael Daniel Keller · Children'S Research Institute · R01 · FY2020 · HL

Early HIV Effects on Gut Immunity and Inflammation for Seeding Viral Reservoirs

$735,785

Satya Dandekar · University Of California At Davis · R01 · FY2020 · AI

Correlates of Vaccine-Induced, Tunable-Protection in an Outbred Tularemia Model

$735,765

Karsten R.o. Hazlett · Albany Medical College · R01 · FY2018 · AI

Structure and Function of EBV Protein Complexes that Trigger Epithelial Cell Entry

$735,750

Richard M Longnecker · Northwestern University At Chicago · R01 · FY2018 · AI

Optimizing Antibody Vaccines Against HIV

$735,687

William Schief · Massachusetts General Hospital · P01 · FY2017 · AI

Primary Care Based Depression Prevention in Adolescents: Intervention Optimization in Preparation for Implementation Study

$735,620

Benjamin W Van Voorhees · University Of Illinois At Chicago · R01 · FY2022 · MH

International Research in Cambodia: Tropical Medicine and Vector Research

$735,562

Jessica Manning · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Tuberculosis and T cell Recognition

$735,535

Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2016 · AI

Predicting protective T-cell responses in Tuberculosis using a systems biology approach

$735,488

Denise E Kirschner · University Of Michigan At Ann Arbor · R01 · FY2017 · AI

Molecular Characterization of the SARS-CoV-2 Helicase and High-Throughput Screening to Identify Small Molecule SARS-CoV-2 Helicase Inhibitors as Anti-Viral Medicines

$735,446

Robert Brosh · National Institute On Aging · ZIA · FY2021 · AG

Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination

$735,422

Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2024 · AI

Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination

$735,422

Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2023 · AI

Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination

$735,422

Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2021 · AI

Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors

$735,387

Kenner Rice · National Institute On Drug Abuse · ZIA · FY2020 · DA

Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors

$735,387

Kenner Rice · National Institute On Drug Abuse · ZIA · FY2018 · DA

Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors

$735,387

Kenner Rice · National Institute On Drug Abuse · ZIA · FY2021 · DA

Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors

$735,387

Kenner Rice · National Institute On Drug Abuse · ZIA · FY2019 · DA

Cell-specific nanocarrier with endocytic and endosomolytic activities for therapeutic genome editing

CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS

Poxvirus Modulation of Immune Responses

Penile transmission and neutralization of pathogenic SIVsmm

Penile transmission and neutralization of pathogenic SIVsmm

Penile transmission and neutralization of pathogenic SIVsmm

Plant-derived vaccines against hepatitis C Cooperative *

Defining Protective CMV Immunity after Transplantation

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment Following Hematopoietic Stem Cell Transplantation

Early HIV Effects on Gut Immunity and Inflammation for Seeding Viral Reservoirs

Correlates of Vaccine-Induced, Tunable-Protection in an Outbred Tularemia Model

Structure and Function of EBV Protein Complexes that Trigger Epithelial Cell Entry

Optimizing Antibody Vaccines Against HIV

Primary Care Based Depression Prevention in Adolescents: Intervention Optimization in Preparation for Implementation Study

International Research in Cambodia: Tropical Medicine and Vector Research

Tuberculosis and T cell Recognition

Predicting protective T-cell responses in Tuberculosis using a systems biology approach

Molecular Characterization of the SARS-CoV-2 Helicase and High-Throughput Screening to Identify Small Molecule SARS-CoV-2 Helicase Inhibitors as Anti-Viral Medicines

Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination

Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination

Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination

Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors

Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors

Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors

Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors